Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Type I Diabetes I: Introduction

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

GWAS of random glucose in 476,326 individuals provide insights into diabetes pathophysiology, complications and treatment stratification.

Nature genetics·2023

Same author

Genetic insights into resting heart rate and its role in cardiovascular disease.

Nature communications·2023

Same author

Genome-wide association study and functional characterization identifies candidate genes for insulin-stimulated glucose uptake.

Nature genetics·2023

Same author

Genome-wide mRNA profiling in urinary extracellular vesicles reveals stress gene signature for diabetic kidney disease.

iScience·2023

Same author

Identification of biomarkers for glycaemic deterioration in type 2 diabetes.

Nature communications·2023

Same author

Desmoglein-2 is important for islet function and β-cell survival.

Cell death & disease·2022

Search research articles

Related Experiment Video

Updated: Jul 3, 2026

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing (ChIP-seq)

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing (ChIP-seq)

Published on: April 19, 2013

Genes and type 2 diabetes mellitus.

Leif Groop¹, Valeriya Lyssenko

¹Department of Clinical Sciences/Diabetes & Endocrinology, Lund University, University Hospital Malmoe, 20502, Malmoe, Sweden. leif.groop@med.lu.se

Current Diabetes Reports

|July 16, 2008

Summary

Genetic complexity of type 2 diabetes mellitus (T2DM) is increasingly understood through genome-wide association studies. Epigenetic factors like DNA methylation may also play a role in T2DM development and age-related gene expression changes.

More Related Videos

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Related Experiment Videos

Last Updated: Jul 3, 2026

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing (ChIP-seq)

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing (ChIP-seq)

Published on: April 19, 2013

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Area of Science:

Genetics
Epigenetics
Molecular Biology

Background:

Type 2 diabetes mellitus (T2DM) genetics research has advanced significantly since 2007.
Genome-wide association studies have identified 11 genes consistently linked to T2DM.
The role of epigenetic modifications, such as DNA methylation and histone acetylation, in T2DM is an emerging area of research.

Purpose of the Study:

To review genes recently associated with type 2 diabetes mellitus.
To highlight the growing understanding of T2DM's genetic complexity.
To explore the potential impact of epigenetic changes on T2DM and age-related gene expression.

Main Methods:

Review of published genome-wide association studies (GWAS) on T2DM genetics.
Analysis of identified genes consistently associated with T2DM.
Discussion of epigenetic mechanisms including DNA methylation and histone modifications.

Main Results:

Discovery of 11 genes consistently associated with T2DM through GWAS.
Identification of T2DM genetic complexity.
Emerging understanding of epigenetic influences on T2DM and age-related gene expression.

Conclusions:

Genome-wide association studies have been pivotal in understanding T2DM genetics.
Epigenetic mechanisms, including DNA methylation, are likely to contribute to T2DM pathogenesis.
Future whole-genome methylation studies may further elucidate the role of epigenetics in T2DM.